MDS+AML MATTER

To address the many challenges faced by members of the interdisciplinary care team involved in the diagnosis and treatment of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), the American Society of Hematology (ASH), American Society for Clinical Pathology (ASCP), National Marrow Donor Program (NMDP), Oncology Nursing Society (ONS), and The France Foundation have partnered to create MDS+AML MATTER, a free education program that includes opportunities for both live and online learning.